The excretion of taurine during deoxypyridoxine administration in Downs' syndrome patients and controls.
D000293:Adolescent; D000963:Antimetabolites / Q000494:pharmacology*; D002648:Child; D003545:Cysteine / Q000378:metabolism; D004314:Down Syndrome / Q000378:metabolism* / Q000652:urine*; D005260:Female; D006801:Humans; D011736:Pyridoxine / Q000494:pharmacology*; D013654:Taurine / Q000378:metabolism* / Q000652:urine*
D000963:Antimetabolites; D013654:Taurine; D003545:Cysteine; D011736:Pyridoxine